OT: Autism Study on Promising Supplement Approved

[Guest guest]

Autism Study on Promising Supplement Approved

Natural Cellular Defense (NCD), a safe, natural, inert mineral

supplement has generated many encouraging reports from parents of

autistic children. NCD has attracted the interest of some of the

leading autism researchers and physicians. A randomized, double-

blind, placebo-controlled study designed to evaluate the benefits of

NCD Zeolite on Autism Spectrum Disorders was approved by BioMed IRB

on June 7, 2006.

San Diego, California - June 7, 2006

BioMed IRB of San Diego, California has approved a clinical trial

that seeks to evaluate the benefits of adding a patented supplement,

NCD zeolite, to the diet of children diagnosed with Autism Spectrum

Disorders. Natural Cellular Defense is purified clinoptilolite, a

type of zeolite, suspended in solution. The zeolite is purified

using a patented process and named NCD Zeolite™.

This form of zeolite is one of the few negatively charged minerals

in nature, and it has a microscopic honeycomb-like crystalline

structure of cavities and cages. Animal studies show that they have

the ability to attract, trap, bind and remove various heavy metals

and toxins such as mercury, lead and arsenic.

The study's eighty autistic children will be divided into two

groups. One group is receiving the NCD zeolite and the other the

placebo for ninety days. Both groups will be measured using a

variety of established instruments for autism diagnosis and

treatment evaluation. Further, since other animal and human studies

with zeolite have demonstrated the ability for zeolite to remove

heavy metals, a portion of the participants will receive a series of

urine excretion tests designed to detect levels of heavy metal

excretion. If previous studies in adults hold true for these

autistic children, the researchers may see excretion rates as high

as 10 times over their baseline.

At the end of the ninety day study period, those receiving the

placebo will then begin taking the NCD and be tracked for ninety

more days.

Two sites have been approved so far. In Plano, Texas, Dr. Seshagiri

Rao, a Board Certified Pediatrician is the lead investigator. The

second site, in Baton Rouge, Louisiana is lead by Dr.

Cave. Both sites have begun recruiting for study participants.

Visit www.ZeoliteAutismStudy.com to learn how to apply.

Professor , PhD will conduct the study data analysis. Dr.

has previously published studies on the high level of mercury

toxicity common in many autistic children. Other studies suggest a

possible link between Thirmersol concentration found in many

vaccines and the high mercury levels in autistic children.

Contact Forrist Lytehaause for more insights into this topic. Direct

line: Email: Coordinator@....

Other helpful information regarding the study can be found at:

www.ZeoliteAutismStudy.com.

For More Information Contact:

Forrist Lytehaause

Coordinator@...

www.ZeoliteAutismStudy.com